Oncology Institute (DFPH) Change in Accured Expenses (2020 - 2026)

Oncology Institute (DFPH) has 7 years of Change in Accured Expenses data on file, last reported at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 52.63% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $903000.0 (down 86.46% YoY), and the FY2025 full-year result was -$448000.0, down 104.73% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $3.9 million, up from -$2.8 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $5.4 million in Q1 2024 and bottomed at -$3.4 million in Q2 2024.
• The 5-year median for Change in Accured Expenses is $526000.0 (2022), against an average of $1.1 million.
• The widest annual swing landed in 2023, when Change in Accured Expenses slumped 332.23%; it then surged 766.83% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at -$545000.0 in 2022, then jumped by 609.72% to $2.8 million in 2023, then jumped by 67.6% to $4.7 million in 2024, then plunged by 160.93% to -$2.8 million in 2025, then jumped by 238.1% to $3.9 million in 2026.
• The last three Change in Accured Expenses figures came in at $3.9 million (Q1 2026), -$2.8 million (Q4 2025), and $127000.0 (Q3 2025), per Business Quant data.

Peer Comparison